Annual FCF:
$182.80M+$253.64M(+358.02%)Summary
- As of today, PTGX annual free cash flow is $182.80 million, with the most recent change of +$253.64 million (+358.02%) on December 31, 2024.
- During the last 3 years, PTGX annual free cash flow has risen by +$291.76 million (+267.76%).
- PTGX annual free cash flow is now at all-time high.
Performance
PTGX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$29.59M-$154.41M(-123.71%)Summary
- As of today, PTGX quarterly free cash flow is -$29.59 million, with the most recent change of -$154.41 million (-123.71%) on June 30, 2025.
- Over the past year, PTGX quarterly free cash flow has dropped by -$298.19 million (-111.02%).
- PTGX quarterly free cash flow is now -111.02% below its all-time high of $268.59 million, reached on June 30, 2024.
Performance
PTGX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$37.10M-$298.19M(-88.94%)Summary
- As of today, PTGX TTM free cash flow is $37.10 million, with the most recent change of -$298.19 million (-88.94%) on June 30, 2025.
- Over the past year, PTGX TTM free cash flow has dropped by -$193.75 million (-83.93%).
- PTGX TTM free cash flow is now -88.94% below its all-time high of $335.29 million, reached on March 31, 2025.
Performance
PTGX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PTGX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +358.0% | -111.0% | -83.9% |
| 3Y3 Years | +267.8% | -112.5% | +134.4% |
| 5Y5 Years | +530.2% | -36.9% | +154.2% |
PTGX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +267.8% | -111.0% | +13.9% | -88.9% | +131.1% |
| 5Y | 5-Year | at high | +267.8% | -111.0% | +22.0% | -88.9% | +131.1% |
| All-Time | All-Time | at high | +267.8% | -111.0% | +22.0% | -88.9% | +131.1% |
PTGX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$29.59M(-123.7%) | $37.10M(-88.9%) |
| Mar 2025 | - | $124.82M(+523.3%) | $335.29M(+83.4%) |
| Dec 2024 | $182.80M(+358.0%) | -$29.49M(-3.0%) | $182.80M(-20.3%) |
| Sep 2024 | - | -$28.64M(-110.7%) | $229.23M(-0.7%) |
| Jun 2024 | - | $268.59M(+1070.7%) | $230.85M(+459.8%) |
| Mar 2024 | - | -$27.67M(-263.3%) | -$64.16M(+9.4%) |
| Dec 2023 | -$70.84M(+35.0%) | $16.94M(+162.7%) | -$70.84M(+40.7%) |
| Sep 2023 | - | -$27.02M(-2.3%) | -$119.49M(-1.4%) |
| Jun 2023 | - | -$26.41M(+23.1%) | -$117.84M(-11.9%) |
| Mar 2023 | - | -$34.36M(-8.4%) | -$105.35M(+3.3%) |
| Dec 2022 | -$108.93M(+0.0%) | -$31.70M(-25.0%) | -$108.93M(-4.4%) |
| Sep 2022 | - | -$25.36M(-82.1%) | -$104.36M(+3.1%) |
| Jun 2022 | - | -$13.93M(+63.3%) | -$107.73M(+8.7%) |
| Mar 2022 | - | -$37.94M(-39.8%) | -$118.01M(-8.3%) |
| Dec 2021 | -$108.97M(-49.4%) | -$27.14M(+5.6%) | -$108.97M(-8.1%) |
| Sep 2021 | - | -$28.73M(-18.7%) | -$100.82M(-14.0%) |
| Jun 2021 | - | -$24.20M(+16.3%) | -$88.45M(-3.0%) |
| Mar 2021 | - | -$28.90M(-52.1%) | -$85.86M(-17.7%) |
| Dec 2020 | -$72.95M | -$18.99M(-16.1%) | -$72.95M(-6.6%) |
| Sep 2020 | - | -$16.36M(+24.3%) | -$68.47M(-3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$21.61M(-35.2%) | -$66.05M(-58.6%) |
| Mar 2020 | - | -$15.99M(-10.2%) | -$41.65M(+2.0%) |
| Dec 2019 | -$42.49M(+15.7%) | -$14.51M(-4.1%) | -$42.49M(-11.3%) |
| Sep 2019 | - | -$13.94M(-601.7%) | -$38.18M(-13.4%) |
| Jun 2019 | - | $2.78M(+116.5%) | -$33.67M(+35.1%) |
| Mar 2019 | - | -$16.83M(-65.0%) | -$51.91M(-2.9%) |
| Dec 2018 | -$50.43M(-1673.1%) | -$10.20M(-8.2%) | -$50.43M(+7.4%) |
| Sep 2018 | - | -$9.42M(+39.1%) | -$54.44M(-1109.0%) |
| Jun 2018 | - | -$15.47M(-0.8%) | -$4.50M(-159.4%) |
| Mar 2018 | - | -$15.35M(-8.0%) | -$1.74M(-154.1%) |
| Dec 2017 | $3.21M(+110.6%) | -$14.21M(-135.1%) | $3.21M(-58.2%) |
| Sep 2017 | - | $40.51M(+419.0%) | $7.68M(+119.3%) |
| Jun 2017 | - | -$12.70M(-22.1%) | -$39.83M(-13.1%) |
| Mar 2017 | - | -$10.40M(-6.9%) | -$35.23M(-16.2%) |
| Dec 2016 | -$30.32M(-105.1%) | -$9.73M(-39.1%) | -$30.32M(-18.7%) |
| Sep 2016 | - | -$7.00M(+13.6%) | -$25.55M(-37.7%) |
| Jun 2016 | - | -$8.10M(-47.6%) | -$18.55M(-77.5%) |
| Mar 2016 | - | -$5.49M(-10.7%) | -$10.45M(-41.3%) |
| Dec 2015 | -$14.78M(-83.8%) | -$4.96M(-103.4%) | -$7.40M(-203.4%) |
| Mar 2015 | - | -$2.44M | -$2.44M |
| Dec 2014 | -$8.04M | - | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Protagonist Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Protagonist Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of PTGX is $182.80M
What is the all-time high annual free cash flow for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual free cash flow is $182.80M
What is Protagonist Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, PTGX annual free cash flow has changed by +$253.64M (+358.02%)
What is Protagonist Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of PTGX is -$29.59M
What is the all-time high quarterly free cash flow for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly free cash flow is $268.59M
What is Protagonist Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, PTGX quarterly free cash flow has changed by -$298.19M (-111.02%)
What is Protagonist Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of PTGX is $37.10M
What is the all-time high TTM free cash flow for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high TTM free cash flow is $335.29M
What is Protagonist Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, PTGX TTM free cash flow has changed by -$193.75M (-83.93%)